Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices
Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices · The Wall Street Journal

In This Article:

Novo Nordisk, which generates around 60% of its sales in the U.S., is among the biggest losers in early European trade.